71 related articles for article (PubMed ID: 24065305)
1. Bone disease in patients awaiting liver transplantation. Has the situation improved in the last two decades?
Monegal A; Navasa M; Peris P; Colmenero J; Cuervo A; Muxí A; Gifre L; Guañabens N
Calcif Tissue Int; 2013 Dec; 93(6):571-6. PubMed ID: 24065305
[TBL] [Abstract][Full Text] [Related]
2. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
4. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
[TBL] [Abstract][Full Text] [Related]
5. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
6. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
7. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in the long term after liver transplantation.
Hamburg SM; Piers DA; van den Berg AP; Slooff MJ; Haagsma EB
Osteoporos Int; 2000; 11(7):600-6. PubMed ID: 11069194
[TBL] [Abstract][Full Text] [Related]
10. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
Dawson-Hughes B; Harris SS; Krall EA; Dallal GE
N Engl J Med; 1997 Sep; 337(10):670-6. PubMed ID: 9278463
[TBL] [Abstract][Full Text] [Related]
12. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
[TBL] [Abstract][Full Text] [Related]
13. Impact of vitamin D, bisphosphonate, and combination therapy on bone mineral density in kidney transplant patients.
Jeon HJ; Han M; Jeong JC; Kim YJ; Kwon HY; Koo TY; Ahn C; Yang J
Transplant Proc; 2013 Oct; 45(8):2963-7. PubMed ID: 24157013
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss.
Buchs N; Helg C; Collao C; Chapuis B; Slosman D; Bonjour JP; Rizzoli R
Osteoporos Int; 2001; 12(10):880-6. PubMed ID: 11716193
[TBL] [Abstract][Full Text] [Related]
15. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study.
Schulte C; Beelen DW; Schaefer UW; Mann K
Osteoporos Int; 2000; 11(4):344-53. PubMed ID: 10928225
[TBL] [Abstract][Full Text] [Related]
16. Long-term persistence of low bone density in orthotopic liver transplantation.
Giannini S; Nobile M; Ciuffreda M; Iemmolo RM; Dalle Carbonare L; Minicuci N; Casagrande F; Destro C; Gerunda GE; Sartori L; Crepaldi G
Osteoporos Int; 2000; 11(5):417-24. PubMed ID: 10912844
[TBL] [Abstract][Full Text] [Related]
17. Bone density, parathyroid hormone, calcium and vitamin D nutritional status of institutionalized elderly subjects.
Deplas A; Debiais F; Alcalay M; Bontoux D; Thomas P
J Nutr Health Aging; 2004; 8(5):400-4. PubMed ID: 15359360
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
Savaj S; Ghods FJ
Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
[TBL] [Abstract][Full Text] [Related]
19. Assessment of serial changes of bone mineral density at lumbar spine and femoral neck before and after liver transplantation.
Xu H; Eichstaedt H
Chin Med J (Engl); 1999 Apr; 112(4):379-81. PubMed ID: 11593545
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
